SRAM
TEVA icon

Spouting Rock Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Spouting Rock Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59,182
Closed -$478K – 167
2022
Q3 		$478K Hold
59,182
– – 0.37% 78
2022
Q2 		$445K Buy
+59,182
New +$516K 0.29% 87
2020
Q4 		– Sell
-33,658
Closed -$303K – 195
2020
Q3 		$303K Sell
33,658
-100,970
-75% -$1.07M 0.14% 127
2020
Q2 		$1.66M Buy
134,628
+45,778
+52% +$518K 0.79% 30
2020
Q1 		$798K Buy
+88,850
New +$910K 0.55% 51

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Spouting Rock Asset Management's TEVA Position: Q4 2022 in Review

Spouting Rock Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 59,182 shares — an estimated $478K sold.

Spouting Rock Asset Management first reported a position in TEVA in Q1 2020 and held it in 5 quarters. The position peaked at $1.66M in Q2 2020. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Spouting Rock Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Spouting Rock Asset Management sold 59,182 Teva Pharmaceuticals shares in Q4 2022, an estimated $478K.
  • Spouting Rock Asset Management first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Spouting Rock Asset Management's Teva Pharmaceuticals position peaked at $1.66M in Q2 2020.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Spouting Rock Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.